1. Koro CE, Lee BH, Bowlin SJ: Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther. 2009, 31: 2608-2617.
2. U.S. Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013. [
http://www.usrds.org/atlas.aspx
]
3. Laliberte R, Bookhart B, Vekeman F, Corral M, Duh MS, Bailey RA, Piech CT, Lefebvre P: Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009, 15: 312-322.
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Working Group: KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013, 3 (1): 1-150.
5. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 5 (Suppl 1): S1-S266.